Medicare Enrolled
Dr. John Sprandio, M.D.
Hematology & Oncology · Broomall, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sprandio from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sprandio?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sprandio
Dr. John Sprandio is a hematology & oncology specialist in Broomall, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sprandio performed 76,460 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Sprandio received a total of $5,761 from 66 pharmaceutical and/or device companies across 277 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sprandio is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 9% volume in PA
$5,761 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗76,460
Medicare services
Top 9% in PA for hematology & oncology
Not available
Unique patients (not deduplicated)
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
25,920 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
15,630 | $2 | $21 |
| Pembrolizumab injection (Keytruda) | 14,000 | $43 | $147 |
| Denosumab injection (Prolia/Xgeva) | 8,640 | $19 | $70 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,463 | $0 | $1 |
| Iron infusion (Monoferric) | 3,000 | $17 | $75 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,073 | $8 | $30 |
| Anti-nausea injection (Aloxi/palonosetron) | 870 | $1 | $122 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
850 | $144 | $301 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
696 | $8 | $19 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
327 | $12 | $93 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
324 | $112 | $686 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
264 | $104 | $224 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
254 | $24 | $152 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
231 | $1 | $9 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
178 | $54 | $304 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
147 | $1 | $19 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
118 | $56 | $334 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
115 | $62 | $205 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
110 | $13 | $105 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
90 | $24 | $156 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
86 | $11 | $73 |
| New patient office visit, complex (60-74 min) | 21 | $181 | $432 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
20 | $27 | $69 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
17 | $75 | $182 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
16 | $32 | $56 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
5.1% high complexity
90.7% medium
4.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,761
Total received (2018-2024)
Avg $823/year across 7 years
Top 31% in PA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
277
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,316
2023
$986
2022
$626
2021
$405
2020
$573
2019
$645
2018
$1,210
Payments by company (2024)
SHIELD THERAPEUTICS INC
$215
PFIZER INC.
$175
Janssen Biotech, Inc.
$90
Bayer Healthcare Pharmaceuticals Inc.
$76
AstraZeneca Pharmaceuticals LP
$64
Takeda Pharmaceuticals U.S.A., Inc.
$56
Celgene Corporation
$52
Sumitomo Pharma America, Inc.
$51
E.R. Squibb & Sons, L.L.C.
$46
Eisai Inc.
$46
Genmab U.S., Inc.
$44
Janssen Pharmaceuticals, Inc
$44
GENZYME CORPORATION
$34
GlaxoSmithKline, LLC.
$32
Aveo Pharmaceuticals, Inc.
$27
Kite Pharma, Inc.
$27
Amneal Pharmaceuticals LLC
$26
SERVIER PHARMACEUTICALS LLC
$24
Daiichi Sankyo Inc.
$23
PUMA BIOTECHNOLOGY, INC.
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
ARRAY BIOPHARMA INC
$20
Rigel Pharmaceuticals, Inc.
$20
Ipsen Biopharmaceuticals, Inc
$19
Astellas Pharma US Inc
$18
Merck Sharp & Dohme LLC
$18
Genentech USA, Inc.
$14
Gilead Sciences, Inc.
$14
Top 3 companies account for 36.4% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$537
PFIZER INC.
$408
AstraZeneca Pharmaceuticals LP
$345
Amgen Inc.
$307
Celgene Corporation
$282
Genentech USA, Inc.
$271
SHIELD THERAPEUTICS INC
$215
GENZYME CORPORATION
$198
Seagen Inc.
$193
Novartis Pharmaceuticals Corporation
$182
Servier Pharmaceuticals LLC
$159
Pharmacyclics LLC, An AbbVie Company
$159
Astellas Pharma US Inc
$135
Takeda Pharmaceuticals U.S.A., Inc.
$127
Janssen Biotech, Inc.
$124
Merck Sharp & Dohme Corporation
$114
Eisai Inc.
$114
Merck Sharp & Dohme LLC
$114
Bayer Healthcare Pharmaceuticals Inc.
$97
Gilead Sciences, Inc.
$96
Daiichi Sankyo Inc.
$84
Incyte Corporation
$77
Kite Pharma, Inc.
$73
MorphoSys, US Inc.
$70
MEDIVATION FIELD SOLUTIONS LLC
$68
Sumitomo Pharma America, Inc.
$67
GlaxoSmithKline, LLC.
$67
TerSera Therapeutics LLC
$60
Bayer HealthCare Pharmaceuticals Inc.
$53
Seattle Genetics, Inc.
$51
AMAG Pharmaceuticals, Inc.
$46
Genmab U.S., Inc.
$44
Janssen Pharmaceuticals, Inc
$44
AVEO Pharmaceuticals, Inc.
$44
JAZZ PHARMACEUTICALS INC.
$43
Puma Biotechnology, Inc.
$43
EISAI INC.
$39
Ipsen Biopharmaceuticals, Inc
$39
Jazz Pharmaceuticals Inc.
$38
EMD Serono, Inc.
$32
Exelixis Inc.
$30
Aveo Pharmaceuticals, Inc.
$27
Amneal Pharmaceuticals LLC
$26
Spectrum Pharmaceuticals Inc.
$25
SERVIER PHARMACEUTICALS LLC
$24
Fresenius Kabi USA, LLC
$24
G1 Therapeutics, Inc.
$24
Stemline Therapeutics Inc.
$23
PUMA BIOTECHNOLOGY, INC.
$22
Verastem, Inc.
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
Mirati Therapeutics, Inc.
$21
Regeneron Healthcare Solutions, Inc.
$20
ABBVIE INC.
$20
ARRAY BIOPHARMA INC
$20
Rigel Pharmaceuticals, Inc.
$20
Mylan Institutional Inc.
$17
Heron Therapeutics, Inc.
$16
AbbVie Inc.
$16
Teva Pharmaceuticals USA, Inc.
$14
Lilly USA, LLC
$12
Mylan Pharmaceuticals Inc.
$12
INSYS Therapeutics Inc
$12
Dendreon Pharmaceuticals LLC
$12
Prometheus Laboratories Inc.
$12
Aurobindo Pharma USA, Inc.
$11
Top 3 companies account for 22.4% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADCETRIS · AVASTIN · Abraxane · Alecensa · Avastin · BENDEKA · BOSULIF · BRAFTOVI · Bavencio · CALQUENCE · CAMZYOS · CARVYKTI · CINVANTI · COSELA · Cabometyx · Copiktra · DARZALEX · ELIQUIS · ELITEK · EMPLICITI · ENJAYMO · Enhertu · Erivedge · Erleada · FERAHEME · FOTIVDA · FRUZAQLA · Folotyn · Fulphila · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kabiven · LIBTAYO · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NINLARO · Nerlynx · Nplate · Nubeqa · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PROVENGE · Perjeta · Phesgo · Pomalyst · Proleukin · REBLOZYL · ROLVEDON · RYBREVANT · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TIBSOVO · TUKYSA · Tivdak · Trodelvy · VENCLEXTA · VERZENIO · VYXEOS · Vectibix · Venclexta · Voranigo · XARELTO · XTANDI · Xermelo · Xtandi · Yescarta · ZEPZELCA · ZOLADEX · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
272
County median income
$88,576
Nearest hospital to ZIP centroid (approximate)
BRYN MAWR HOSPITAL
3.8 mi
3.8 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sprandio is a mixed practice specialist, with above-average Medicare volume (top 9% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sprandio experienced with filgrastim injection (nivestym) for white blood cells?
Based on Medicare claims data, Dr. Sprandio performed 25,920 filgrastim injection (nivestym) for white blood cells services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Sprandio receive payments from pharmaceutical companies?
Yes. Dr. Sprandio received a total of $5,761 from 66 companies across 277 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sprandio's costs compare to other hematology & oncology specialists in Broomall?
Dr. Sprandio's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sprandio) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Broomall
Browse hematology & oncology specialists in Broomall ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in PA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in PA
Which PA hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology